High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2
Martine E.D. Chamuleau(Hovon), Arjan A. van de Loosdrecht(Dutch Cancer Society), S.M.G. Jirka(Amsterdam UMC Location Vrije Universiteit Amsterdam), L. van Dreunen(Amsterdam UMC Location VUmc), Adri Zevenbergen(Amsterdam UMC Location VUmc), Anna van Rhenen(Amsterdam UMC Location Vrije Universiteit Amsterdam), G.J. Ossenkoppele(Amsterdam UMC Location Vrije Universiteit Amsterdam), Gerrit‐Jan Schuurhuis(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 42
Related Papers
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633